Literature DB >> 30939123

IL-26 contributes to host defense against intracellular bacteria.

Angeline Tilly Dang1,2, Rosane Mb Teles1, David I Weiss1,2, Kislay Parvatiyar2, Euzenir N Sarno3, Maria T Ochoa4, Genhong Cheng2, Michel Gilliet5, Barry R Bloom6, Robert L Modlin1,2.   

Abstract

IL-26 is an antimicrobial protein secreted by Th17 cells that has the ability to directly kill extracellular bacteria. To ascertain whether IL-26 contributes to host defense against intracellular bacteria, we studied leprosy, caused by the obligate intracellular pathogen Mycobacterium leprae, as a model. Analysis of leprosy skin lesions by gene expression profiling and immunohistology revealed that IL-26 was more strongly expressed in lesions from the self-limited tuberculoid compared with expression in progressive lepromatous patients. IL-26 directly bound to M. leprae in axenic culture and reduced bacteria viability. Furthermore, IL-26, when added to human monocyte-derived macrophages infected with M. leprae, entered the infected cell, colocalized with the bacterium, and reduced bacteria viability. In addition, IL-26 induced autophagy via the cytoplasmic DNA receptor stimulator of IFN genes (STING), as well as fusion of phagosomes containing bacilli with lysosomal compartments. Altogether, our data suggest that the Th17 cytokine IL-26 contributes to host defense against intracellular bacteria.

Entities:  

Keywords:  Cellular immune response; Immunology; Infectious disease

Year:  2019        PMID: 30939123      PMCID: PMC6486355          DOI: 10.1172/JCI99550

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  66 in total

1.  Microarray analysis of Mycobacterium tuberculosis-infected monocytes reveals IL26 as a new candidate gene for tuberculosis susceptibility.

Authors:  José M Guerra-Laso; Sara Raposo-García; Silvia García-García; Cristina Diez-Tascón; Octavio M Rivero-Lezcano
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

2.  NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy.

Authors:  Mirjam Schenk; Stephan R Krutzik; Peter A Sieling; Delphine J Lee; Rosane M B Teles; Maria Teresa Ochoa; Evangelia Komisopoulou; Euzenir N Sarno; Thomas H Rea; Thomas G Graeber; Soohyun Kim; Genhong Cheng; Robert L Modlin
Journal:  Nat Med       Date:  2012-03-25       Impact factor: 53.440

3.  Pathology and bacteriology of early lesions in leprosy.

Authors:  D S Ridley
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Apr-Jun

4.  Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri.

Authors:  A Knappe; S Hör; S Wittmann; H Fickenscher
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26.

Authors:  Stephan Meller; Jeremy Di Domizio; Kui S Voo; Heike C Friedrich; Georgios Chamilos; Dipyaman Ganguly; Curdin Conrad; Josh Gregorio; Didier Le Roy; Thierry Roger; John E Ladbury; Bernhard Homey; Stanley Watowich; Robert L Modlin; Dimitrios P Kontoyiannis; Yong-Jun Liu; Stefan T Arold; Michel Gilliet
Journal:  Nat Immunol       Date:  2015-07-13       Impact factor: 25.606

6.  Molecular determination of Mycobacterium leprae viability by use of real-time PCR.

Authors:  Alejandra N Martinez; Ramanuj Lahiri; Tana L Pittman; David Scollard; Richard Truman; Milton O Moraes; Diana L Williams
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

7.  IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation.

Authors:  Murielle Corvaisier; Yves Delneste; Henry Jeanvoine; Laurence Preisser; Simon Blanchard; Erwan Garo; Emmanuel Hoppe; Benjamin Barré; Maurice Audran; Béatrice Bouvard; Jean-Paul Saint-André; Pascale Jeannin
Journal:  PLoS Biol       Date:  2012-09-25       Impact factor: 8.029

8.  Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells.

Authors:  Franca Gerosa; Barbara Baldani-Guerra; Lyudmila A Lyakh; Giovanna Batoni; Semih Esin; Robin T Winkler-Pickett; Maria Rita Consolaro; Mario De Marchi; Daniela Giachino; Angela Robbiano; Marco Astegiano; Angela Sambataro; Robert A Kastelein; Giuseppe Carra; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2008-05-19       Impact factor: 14.307

9.  Inability to sustain intraphagolysosomal killing of Staphylococcus aureus predisposes to bacterial persistence in macrophages.

Authors:  Jamil Jubrail; Paul Morris; Martin A Bewley; Simon Stoneham; Simon A Johnston; Simon J Foster; Andrew A Peden; Robert C Read; Helen M Marriott; David H Dockrell
Journal:  Cell Microbiol       Date:  2015-09-02       Impact factor: 3.715

10.  Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.

Authors:  Michele D Tameris; Mark Hatherill; Bernard S Landry; Thomas J Scriba; Margaret Ann Snowden; Stephen Lockhart; Jacqueline E Shea; J Bruce McClain; Gregory D Hussey; Willem A Hanekom; Hassan Mahomed; Helen McShane
Journal:  Lancet       Date:  2013-03-23       Impact factor: 79.321

View more
  13 in total

1.  IL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells.

Authors:  David I Weiss; Feiyang Ma; Alexander A Merleev; Emanual Maverakis; Michel Gilliet; Samuel J Balin; Bryan D Bryson; Maria Teresa Ochoa; Matteo Pellegrini; Barry R Bloom; Robert L Modlin
Journal:  J Immunol       Date:  2019-06-24       Impact factor: 5.422

2.  Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis.

Authors:  Ryo Hatano; Takumi Itoh; Haruna Otsuka; Sayo Okamoto; Eriko Komiya; Satoshi Iwata; Thomas M Aune; Nam H Dang; Kyoko Kuwahara-Arai; Kei Ohnuma; Chikao Morimoto
Journal:  MAbs       Date:  2019-08-18       Impact factor: 5.857

3.  Interleukin-26 is overexpressed in human sepsis and contributes to inflammation, organ injury, and mortality in murine sepsis.

Authors:  Hongmei Tu; Xiaofei Lai; Jiaxi Li; Lili Huang; Yi Liu; Ju Cao
Journal:  Crit Care       Date:  2019-08-29       Impact factor: 9.097

Review 4.  Targeting Autophagy as a Strategy for Developing New Vaccines and Host-Directed Therapeutics Against Mycobacteria.

Authors:  Emily J Strong; Sunhee Lee
Journal:  Front Microbiol       Date:  2021-01-14       Impact factor: 6.064

Review 5.  Shedding Light on Autophagy During Human Tuberculosis. A Long Way to Go.

Authors:  Joaquin Miguel Pellegrini; Nancy Liliana Tateosian; María Paula Morelli; Verónica Edith García
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

Review 6.  Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities.

Authors:  Alba Llibre; Martin Dedicoat; Julie G Burel; Caroline Demangel; Matthew K O'Shea; Claudio Mauro
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

Review 7.  The STING1 network regulates autophagy and cell death.

Authors:  Ruoxi Zhang; Rui Kang; Daolin Tang
Journal:  Signal Transduct Target Ther       Date:  2021-06-02

8.  The cellular architecture of the antimicrobial response network in human leprosy granulomas.

Authors:  Feiyang Ma; Travis K Hughes; Rosane M B Teles; Priscila R Andrade; Bruno J de Andrade Silva; Olesya Plazyo; Lam C Tsoi; Tran Do; Marc H Wadsworth; Aislyn Oulee; Maria Teresa Ochoa; Euzenir N Sarno; M Luisa Iruela-Arispe; Eynav Klechevsky; Bryan Bryson; Alex K Shalek; Barry R Bloom; Johann E Gudjonsson; Matteo Pellegrini; Robert L Modlin
Journal:  Nat Immunol       Date:  2021-06-24       Impact factor: 31.250

9.  Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-κB Pathway.

Authors:  Yi-Hsuan Lin; Yi-Hsun Wang; Yi-Jen Peng; Feng-Cheng Liu; Gu-Jiun Lin; Shing-Hwa Huang; Huey-Kang Sytwu; Chia-Pi Cheng
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

10.  Interleukin-26 activates macrophages and facilitates killing of Mycobacterium tuberculosis.

Authors:  Heike C Hawerkamp; Lasse van Geelen; Jan Korte; Jeremy Di Domizio; Marc Swidergall; Afaque A Momin; Francisco J Guzmán-Vega; Stefan T Arold; Joachim Ernst; Michel Gilliet; Rainer Kalscheuer; Bernhard Homey; Stephan Meller
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.